Skip header and navigation

Narrow By

2 records – page 1 of 1.

Managing cardiometabolic risk : an evolving approach to patient care

https://libcat.nshealth.ca/en/permalink/provcat22972
Watson, Karol. --[s.l.]: Sanofi Aventis , 2006.
Call Number
WG 120 M266 2006
Location
Halifax Infirmary
Call Number
WG 120 M266 2006
Author
Watson, Karol
Place of Publication
[s.l.]
Publisher
Sanofi Aventis
Date of Publication
2006
Physical Description
24 p.
Subjects (MeSH)
Cardiovascular System - metabolism
Cardiovascular Diseases - etiology
Cardiovascular Diseases - prevention & control
Format
Book
Location
Halifax Infirmary
Loan Period
3 weeks
Less detail

Pulmonary Artery Hypertension (PAH) Program

https://libcat.nshealth.ca/en/permalink/chpams34865
Nova Scotia Health Authority. Pulmonary Arterial Hypertension Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1103
Available Online
View Pamphlet
The Pulmonary Arterial Hypertension (PAH) Program coordinates the assessment, care, and treatment of people with suspected or diagnosed pulmonary arterial hypertension. This pamphlet describes PAH, a rare condition that causes high blood pressure in the blood vessels that connect the heart and lungs (pulmonary arteries). This pamphlet explains what causes PAH, why you have been referred to the PAH Program, how the PAH Program will help you, what tests will be done, and how PAH is treated. A lis…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pulmonary Arterial Hypertension Program
Alternate Title
PAH Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.): digital, PDF file
Subjects (MeSH)
Familial Primary Pulmonary Hypertension
Cardiovascular Diseases - diagnosis
Subjects (LCSH)
Pulmonary hypertension
Cardiovascular system--Diseases--Diagnosis
Abstract
The Pulmonary Arterial Hypertension (PAH) Program coordinates the assessment, care, and treatment of people with suspected or diagnosed pulmonary arterial hypertension. This pamphlet describes PAH, a rare condition that causes high blood pressure in the blood vessels that connect the heart and lungs (pulmonary arteries). This pamphlet explains what causes PAH, why you have been referred to the PAH Program, how the PAH Program will help you, what tests will be done, and how PAH is treated. A list of resources for more information is included.
Responsibility
Prepared by: Pulmonary Arterial Hypertension Program
Pamphlet Number
1103
Less detail